Dong-A Pharmaceutical Executive and Leadership Team

Chong Kim, the Chief Financial Officer & Chief Operating Officer at Dong-A Pharmaceutical, directs the company's financial strategy and operational execution. This dual role involves overseeing all fiscal activities, including budgeting, financial planning, and reporting, while simultaneously managing the day-to-day operations across various business units. Kim ensures efficient resource allocation and drives operational excellence to support Dong-A Pharmaceutical's mission of enhancing human health and well-being. The Chief Financial Officer & Chief Operating Officer's leadership is critical in integrating financial discipline with operational effectiveness, particularly within the diverse sectors of medical and digital healthcare, consumer products, and logistics. Chong Kim's strategic oversight guarantees that operational frameworks align with the company's commitment to social responsibility and value creation. This executive's focus extends to optimizing supply chains and IT services, ensuring seamless integration of these functions to meet market demands and client needs across South Korea and beyond.

Sung Park, the Group Chief Financial Officer at Dong-A Pharmaceutical, spearheads the financial direction for the entire socio group. This leadership position involves comprehensive management of all financial aspects, including capital allocation, investment strategies, and risk management across the organization's diverse portfolio. Park ensures robust financial health and sustainable growth by aligning fiscal policies with the company's overarching goals of enhancing human health and well-being. The Group Chief Financial Officer's responsibilities extend to fostering strong relationships with financial institutions and stakeholders, securing capital for expansion and innovation. Sung Park's expertise is vital in navigating the complex financial landscape of the healthcare, consumer products, and logistics sectors. This executive drives financial planning and analysis, providing critical insights that inform strategic decision-making and operational adjustments to maximize value for the group and its clients.

Won Kim, the President at Dong-A Pharmaceutical, provides overarching strategic direction and leadership for the organization. This executive role involves guiding the company's vision and ensuring alignment across all business units, including medical and digital healthcare, consumer products, logistics, IT services, and engineering. Kim's leadership focuses on fulfilling the group's social responsibility by enhancing human health and well-being through innovative solutions and consumer-oriented management. The President's mandate includes driving market expansion, fostering strategic partnerships, and championing the company's commitment to creating value. Won Kim's influence is critical in shaping the corporate culture and steering the company towards sustained success and industry leadership. This executive's strategic foresight ensures that Dong-A Pharmaceutical remains at the forefront of healthcare innovation and service delivery.

Jung Kang, the Executive President at Dong-A Pharmaceutical, drives key strategic initiatives and operational enhancements across the group. This senior leadership position focuses on translating the company's mission into actionable plans, ensuring the effective execution of strategies in medical and digital healthcare, consumer products, and logistics. Kang oversees critical functions aimed at improving operational efficiency and expanding market reach, contributing directly to the enhancement of human health and well-being. The Executive President's role involves close collaboration with other senior leaders to foster innovation and maintain a consumer-oriented approach. Jung Kang's leadership is instrumental in navigating market dynamics and ensuring the company's sustained growth and commitment to social responsibility. This executive's focus on operational excellence and strategic development supports Dong-A Pharmaceutical's objective of creating significant value within the industry.